Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4593371
Max Phase: Preclinical
Molecular Formula: C33H38F9N5O9S2
Molecular Weight: 656.77
Molecule Type: Unknown
Associated Items:
ID: ALA4593371
Max Phase: Preclinical
Molecular Formula: C33H38F9N5O9S2
Molecular Weight: 656.77
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[N+](C)(C)CCNC(=O)COc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)sc2c1.O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F
Standard InChI: InChI=1S/C29H36F3N5O5S2.2C2HF3O2/c1-37(2,3)9-8-34-27(39)17-42-20-4-5-24-25(15-20)43-28(35-24)29(6-10-44(40,41)11-7-29)36-26(38)14-19(33)12-18-13-22(31)23(32)16-21(18)30;2*3-2(4,5)1(6)7/h4-5,13,15-16,19H,6-12,14,17,33H2,1-3H3,(H-,34,36,38,39);2*(H,6,7)/t19-;;/m1../s1
Standard InChI Key: HDLBLKVLTOSJKF-JQDLGSOUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 656.77 | Molecular Weight (Monoisotopic): 656.2183 | AlogP: 2.40 | #Rotatable Bonds: 12 |
Polar Surface Area: 140.48 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.48 | CX Basic pKa: 8.38 | CX LogP: -3.39 | CX LogD: -4.41 |
Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.20 | Np Likeness Score: -1.10 |
1. Huang F, Ning M, Wang K, Liu J, Guan W, Leng Y, Shen J.. (2019) Discovery of Highly Polar β-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors., 62 (23): [PMID:31747282] [10.1021/acs.jmedchem.9b01649] |
Source(1):